Submitted by dcc on Thu, 2017-02-16 13:44 Study Title: A Randomized Phase III Trial of Paclitaxel versus Paclitaxel plus Bevacizumab (rhuMAb VEGF) as First-Line Therapy for Locally Recurrent or Metastatic Breast CancerCIRB: Adult CIRB - Late Phase EmphasisLead Group: ECOGStatus: CompletedReview Status: Completed
